Jennewein Biotechnology flags HMOs’ potential in inhibiting infectious diseases

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

18 Sep 2020 --- As industry strides toward a better understanding of the gut microbiome, clear scientific and pharmaceutical standards are needed for live biotherapeutic products... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 Sep 2020 --- Lonza is launching its first probiotic ingredient for the sports nutrition market. TWK10 is a Lactobacillus plantarum probiotic strain that has been clinically... Read More

FormattedPicture

BUSINESS NEWS

17 Sep 2020 --- Kicking off today, Future Food-Tech’s online summit is focalizing how technology can be harnessed to drive personalized nutrition. Positioned as a platform... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

16 Sep 2020 --- Throughout the global COVID-19 pandemic, NutritionInsight is dedicated to bringing its readers all the latest and most relevant industry updates. Visit this... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

15 Sep 2020 --- The adult use of human milk oligosaccharides (HMOs) has the potential to become even bigger than current infant formula usage, according to Odd Hansen,... Read More

trans